Qiagen Draws Early Takeover Interest From EQT, Advent

Qiagen NV, the European molecular testing company, is drawing early takeover interest from firms including EQT AB and Advent, people familiar with the matter said.

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.